Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

MLA

Helle Wulf-Johansson, et al. “Plasma Microfibrillar-Associated Protein 4 Is Not Prognostic of Emphysema Progression but Is Associated with Cardiovascular Disease History and Mortality in COPD Patients.” ERJ Open Research, vol. 5, Apr. 2019, pp. 00021-2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a9dc3524565acd0edffc1689a9b679a3&authtype=sso&custid=ns315887.

APA

Helle Wulf-Johansson, Bruce E. Miller, Jørgen Vestbo, Anders Schlosser, Ruth Tal-Singer, Grith Lykke Sørensen, Sofie Lock Johansson, Ingrid Louise Titlestad, & Uffe Holmskov. (2019). Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients. ERJ Open Research, 5, 00021-2019.

Chicago

Helle Wulf-Johansson, Bruce E. Miller, Jørgen Vestbo, Anders Schlosser, Ruth Tal-Singer, Grith Lykke Sørensen, Sofie Lock Johansson, Ingrid Louise Titlestad, and Uffe Holmskov. 2019. “Plasma Microfibrillar-Associated Protein 4 Is Not Prognostic of Emphysema Progression but Is Associated with Cardiovascular Disease History and Mortality in COPD Patients.” ERJ Open Research 5 (April): 00021-2019. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a9dc3524565acd0edffc1689a9b679a3&authtype=sso&custid=ns315887.